Annually, approximately 50,000 patients receive oral methotrexate treatment from NHS in England and Wales. One hundred thirty-seven patient safety incidents were reported during a 10-year period ...
A 1-year course of methotrexate may help prevent the development of ACPA-negative RA among patients with clinically suspect arthralgia at high-risk for the disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback